These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24121275)

  • 1. The MYB proto-oncogene suppresses monocytic differentiation of acute myeloid leukemia cells via transcriptional activation of its target gene GFI1.
    Zhao L; Ye P; Gonda TJ
    Oncogene; 2014 Aug; 33(35):4442-9. PubMed ID: 24121275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MYB oncogene can suppress apoptosis in acute myeloid leukemia cells by transcriptional repression of DRAK2 expression.
    Ye P; Zhao L; Gonda TJ
    Leuk Res; 2013 May; 37(5):595-601. PubMed ID: 23398943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An acute myeloid leukemia gene, AML1, regulates transcriptional activation and hemopoietic myeloid cell differentiation antagonistically by two alternative spliced forms.
    Tanaka T; Tanaka K; Ogawa S; Kurokawa M; Mitani K; Yazaki Y; Shibata Y; Hirai H
    Leukemia; 1997 Apr; 11 Suppl 3():299-302. PubMed ID: 9209372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA; Hoffman B
    Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated genome-wide chromatin occupancy and expression analyses identify key myeloid pro-differentiation transcription factors repressed by Myb.
    Zhao L; Glazov EA; Pattabiraman DR; Al-Owaidi F; Zhang P; Brown MA; Leo PJ; Gonda TJ
    Nucleic Acids Res; 2011 Jun; 39(11):4664-79. PubMed ID: 21317192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
    Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
    Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
    Lennartsson A; Garwicz D; Lindmark A; Gullberg U
    Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia.
    Yusenko MV; Trentmann A; Casolari DA; Abdel Ghani L; Lenz M; Horn M; Dörner W; Klempnauer S; Mootz HD; Arteaga MF; Mikesch JH; D'Andrea RJ; Gonda TJ; Müller-Tidow C; Schmidt TJ; Klempnauer KH
    Oncogene; 2021 Jul; 40(29):4746-4758. PubMed ID: 33958723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
    Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
    Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Myb associates with PML in nuclear bodies in hematopoietic cells.
    Dahle Ø; Bakke O; Gabrielsen OS
    Exp Cell Res; 2004 Jul; 297(1):118-26. PubMed ID: 15194430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice.
    Basova P; Pospisil V; Savvulidi F; Burda P; Vargova K; Stanek L; Dluhosova M; Kuzmova E; Jonasova A; Steidl U; Laslo P; Stopka T
    Oncogene; 2014 Sep; 33(39):4735-45. PubMed ID: 24121269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth factor independence 1 protects hematopoietic stem cells against apoptosis but also prevents the development of a myeloproliferative-like disease.
    Khandanpour C; Kosan C; Gaudreau MC; Dührsen U; Hébert J; Zeng H; Möröy T
    Stem Cells; 2011 Feb; 29(2):376-85. PubMed ID: 21732494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells.
    Chen J; Kremer CS; Bender TP
    Oncogene; 2006 May; 25(19):2758-72. PubMed ID: 16407849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells.
    Patel G; Tantravahi R; Oh IH; Reddy EP
    Oncogene; 1996 Sep; 13(6):1197-208. PubMed ID: 8808694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminished proteasomal degradation results in accumulation of Gfi1 protein in monocytes.
    Marteijn JA; van der Meer LT; Van Emst L; de Witte T; Jansen JH; van der Reijden BA
    Blood; 2007 Jan; 109(1):100-8. PubMed ID: 16888099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TEL2, an ETS factor expressed in human leukemia, regulates monocytic differentiation of U937 Cells and blocks the inhibitory effect of TEL1 on ras-induced cellular transformation.
    Kawagoe H; Potter M; Ellis J; Grosveld GC
    Cancer Res; 2004 Sep; 64(17):6091-100. PubMed ID: 15342392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The glioma-amplified sequence 41 gene (GAS41) is a direct Myb target gene.
    Braas D; Gundelach H; Klempnauer KH
    Nucleic Acids Res; 2004; 32(16):4750-7. PubMed ID: 15356292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Myb-responsive enhancer of the chicken C/EBPbeta gene.
    Kintscher J; Yamkamon V; Braas D; Klempnauer KH
    Oncogene; 2004 Jul; 23(34):5807-14. PubMed ID: 15195136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gfi1 and Gfi1b: key regulators of hematopoiesis.
    van der Meer LT; Jansen JH; van der Reijden BA
    Leukemia; 2010 Nov; 24(11):1834-43. PubMed ID: 20861919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common themes in the pathogenesis of acute myeloid leukemia.
    Alcalay M; Orleth A; Sebastiani C; Meani N; Chiaradonna F; Casciari C; Sciurpi MT; Gelmetti V; Riganelli D; Minucci S; Fagioli M; Pelicci PG
    Oncogene; 2001 Sep; 20(40):5680-94. PubMed ID: 11607818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.